Clinical Trials Directory

Trials / Completed

CompletedNCT01640353

Sacroiliac Joint Fusion With iFuse Implant System (SIFI)

Status
Completed
Phase
Study type
Observational
Enrollment
194 (actual)
Sponsor
SI-BONE, Inc. · Industry
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the use of the iFuse Implant System to treat degenerative sacroiliitis (arthritis of the SI joint) and sacroiliac disruption (abnormal separation or tearing of the sacroiliac joint). The iFuse Implant System (iFuse device) is a medical device that is surgically implanted into the sacroiliac (SI) joint during a minimally invasive surgical procedure (one that uses a smaller incision and less damage to the skin and other tissues than standard surgery). The purpose of implanting the device is to stabilize and fuse the SI joint.

Conditions

Timeline

Start date
2012-07-01
Primary completion
2015-01-01
Completion
2016-02-01
First posted
2012-07-13
Last updated
2017-03-24
Results posted
2017-03-24

Locations

26 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01640353. Inclusion in this directory is not an endorsement.